T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
XYZ
Block Inc
XYZ
|
+$2.39B |
| 2 |
Carvana
CVNA
|
+$1.82B |
| 3 |
Microsoft
MSFT
|
+$1.5B |
| 4 |
Walt Disney
DIS
|
+$1.25B |
| 5 |
Spotify
SPOT
|
+$1.05B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$2.65B |
| 2 |
Intuit
INTU
|
+$2.08B |
| 3 |
Match Group
MTCH
|
+$1.87B |
| 4 |
Salesforce
CRM
|
+$1.76B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.61B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.08% |
| 2 | Healthcare | 16.24% |
| 3 | Consumer Discretionary | 15.33% |
| 4 | Communication Services | 13.82% |
| 5 | Financials | 12.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2526
Enterprise Financial Services Corp
EFSC
$2.4B
| $337K | ﹤0.01% |
7,435
-4,514
| -38% | -$202K |
|
|
DMTK
2527
DELISTED
DermTech, Inc. Common Stock
DMTK
| $337K | ﹤0.01% |
+10,510
| New | +$369K |
|
2528
Standard BioTools
LAB
$294M
| $336K | ﹤0.01% |
51,061
-7,781
| -13% | -$51.2K |
|
2529
World Acceptance Corp
WRLD
$875M
| $336K | ﹤0.01% |
1,772
+26
| +1% | +$4.8K |
|
|
GRTS
2530
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $336K | ﹤0.01% |
31,144
-172,726
| -85% | -$1.57M |
|
|
RIDE
2531
DELISTED
Lordstown Motors Corp. Class A Common Stock
RIDE
| $336K | ﹤0.01% |
2,807
-103
| -4% | -$10.7K |
|
|
GHL
2532
DELISTED
Greenhill & Co., Inc.
GHL
| $333K | ﹤0.01% |
22,805
-5,100
| -18% | -$75.9K |
|
|
AERI
2533
DELISTED
Aerie Pharmaceuticals
AERI
| $332K | ﹤0.01% |
29,104
-201
| -0.7% | -$2.94K |
|
2534
Brookfield Renewable
BEP
$10.6B
| $331K | ﹤0.01% |
8,972
+3,402
| +61% | +$132K |
|
2535
MP Materials
MP
$9.91B
| $330K | ﹤0.01% |
10,234
+4,153
| +68% | +$144K |
|
2536
Quanex
NX
$981M
| $330K | ﹤0.01% |
15,414
| – | – |
|
|
VRTV
2537
DELISTED
VERITIV CORPORATION
VRTV
| $325K | ﹤0.01% |
3,628
-56
| -2% | -$4.28K |
|
2538
Banc of California
BANC
$3.11B
| $324K | ﹤0.01% |
17,548
-166
| -0.9% | -$2.9K |
|
2539
BioXcel Therapeutics
BTAI
$34.9M
| $324K | ﹤0.01% |
668
+4
| +0.6% | +$1.76K |
|
2540
DigitalOcean
DOCN
$15.6B
| $323K | ﹤0.01% |
+4,163
| New | +$257K |
|
|
KYNB
2541
Kyntra Bio
KYNB
$28.5M
| $323K | ﹤0.01% |
1,265
-18,594
| -94% | -$6.59M |
|
2542
Lindsay Corp
LNN
$1.17B
| $323K | ﹤0.01% |
2,125
-241,916
| -99% | -$39M |
|
2543
Camping World
CWH
$675M
| $322K | ﹤0.01% |
8,276
+76
| +0.9% | +$2.98K |
|
2544
GDS Holdings
GDS
$6.97B
| $321K | ﹤0.01% |
5,676
+76
| +1% | +$4.68K |
|
2545
MiMedx Group
MDXG
$612M
| $319K | ﹤0.01% |
52,651
-2,600
| -5% | -$29.3K |
|
|
PRTY
2546
DELISTED
Party City Holdco Inc.
PRTY
| $318K | ﹤0.01% |
44,786
-2,165
| -5% | -$16.5K |
|
|
DCUE
2547
DELISTED
Dominion Energy, Inc. 2019 Series A Corporate Units
DCUE
| $316K | ﹤0.01% |
+3,267
| New | +$327K |
|
2548
Centrus Energy
LEU
$3.83B
| $314K | ﹤0.01% |
8,111
-42
| -0.5% | -$1.17K |
|
|
NFBK
2549
DELISTED
Northfield Bancorp
NFBK
| $314K | ﹤0.01% |
18,276
+257
| +1% | +$4.23K |
|
2550
Vaxcyte
PCVX
$8.76B
| $314K | ﹤0.01% |
12,381
+2,042
| +20% | +$49.5K |
|
Similar funds
T. Rowe Price Associates's Q3 2021 Portfolio in Review
As of Q3 2021, T. Rowe Price Associates held 3,048 positions worth $1.06T, down 1.6% from $1.08T the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q3 2021 filing shows 131 new, 1,029 increased, 1,524 reduced and 112 closed positions. Its largest new stake was Warby Parker: 17,643,113 shares worth $936M. The largest sale was Visa, an estimated $2.65B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2021 buy was Warby Parker: 17,643,113 shares worth $936M.
- T. Rowe Price Associates added most to Block Inc in Q3 2021, an estimated $2.39B increase.
- T. Rowe Price Associates's biggest Q3 2021 reduction was Visa, cutting an estimated $2.65B.
- T. Rowe Price Associates fully exited Maxim Integrated Products in Q3 2021, selling an estimated $394M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $1.06T portfolio in Q3 2021.
- T. Rowe Price Associates opened 131 new positions and closed 112 in Q3 2021.
- T. Rowe Price Associates's portfolio value fell 1.6% quarter-over-quarter to $1.06T.
Based on T. Rowe Price Associates's 13F filing for Q3 2021, filed 15 Nov 2021.